FI-LAB

Biomarker

5 papers8 findings

Human studies report FI-LAB prediction of mortality in emergency department patients and critically ill acute ischaemic stroke patients at a 24-hour landmark. A preprint reports improved mortality discrimination within MIMIC-IV, while a review describes prediction of 12-month mortality after endovascular therapy for acute ischaemic stroke.

  • Humans4

Effects

1

Mortality discrimination

upin humans1

1 study
  1. FI-LAB improves mortality discrimination in humans (+0.0132 AUC (95% CI 0.0081 to 0.0184)).

    Humansinternally in MIMIC-IV patients

    Added prognostic value of a laboratory frailty index for hospital mortality in surgical intensive care: a two-database cohort study

    Research Square16 Sep 2026Preprint

Associations

6

Mortality

upin humans2HR 2.04

2 studies
  1. FI-LAB predicts mortality in humans (AUC 0.774 to 0.808).

    Humanscritically ill acute ischemic stroke patients at 24-h landmarkn = 1,296

    Baseline and 72-h dynamic laboratory deficit burden for mortality through day 90 after acute ischemic stroke in critical care: landmark analyses with temporal validation

    Frontiers in neurology3 Sep 2026

  2. FI-LAB predicts mortality in humans (HR 2.04, 95% CI 1.99–2.09).

    Humansin emergency department patients (MIMIC-IV-ED)

    Evaluation of the FI-Lab, a laboratory-based, automated frailty index for acute care: A multicohort study

    PLoS medicine1 Sep 2026

12-month mortality

upin humans1HR 3.61

1 study
  1. FI-LAB predicts 12-month mortality in humans (adjusted HR 3.61, 95% CI 1.98-6.61).

    Reviewafter endovascular therapy for acute ischaemic stroke

    Frailty as a Predictor of Clinical Outcomes After Acute Ischemic Stroke in Older Adults: A Systematic Review and Meta-Analysis

    Cureus19 Aug 2026

Malignant arrhythmia

upin humans1

1 study
  1. FI-LAB raises the risk of malignant arrhythmia in humans (SHR = 2.68, 95% CI: 1.39-5.18).

    Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)

    Association between frailty and clinical outcomes in critically ill coronary artery disease patients: A retrospective cohort study

    Science progress11 Aug 2026

More on Malignant arrhythmia

1-year mortality

upin humans1HR 3.6

1 study
  1. FI-LAB raises the risk of 1-year mortality in humans (HR = 3.60, 95% CI: 2.56-5.06).

    Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)

    Association between frailty and clinical outcomes in critically ill coronary artery disease patients: A retrospective cohort study

    Science progress11 Aug 2026

28-day mortality

upin humans1HR 3.42

1 study
  1. FI-LAB raises the risk of 28-day mortality in humans (HR = 3.42, 95% CI: 2.17-5.40).

    Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)

    Association between frailty and clinical outcomes in critically ill coronary artery disease patients: A retrospective cohort study

    Science progress11 Aug 2026

In-hospital mortality

upin humans1OR 4.41

1 study
  1. FI-LAB raises the risk of in-hospital mortality in humans (OR = 4.41, 95% CI: 2.60-7.48).

    Humanscritically ill patients with coronary artery disease (severe frailty vs mild frailty)

    Association between frailty and clinical outcomes in critically ill coronary artery disease patients: A retrospective cohort study

    Science progress11 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 3Sep 2026: 3Oct 2026: 06 in 12 months